Table 3.
The changes of body weight, BMI, and BFP of participants enrolled over time.
| Results | Probiotics n = 47 Mean (SD) | Placebo n = 45 Mean (SD) | ||||
|---|---|---|---|---|---|---|
| Pre | Post | Pa-value | Pre | Post | Pb-value | |
| Weight, kg | 56.11 (6.53) | 56.20 (6.29) | 0.15 | 58.05 (7.29) | 59.40 (7.19) | 0.001 |
| BMI | 22.66 (2.34) | 22.83 (2.17) | 0.13 | 23.11 (2.81) | 23.67 (2.73) | 0.001 |
| BFP, % | 31.94 (4.76) | 31.99 (4.67) | 0.86 | 32.33 (5.42) | 36.19 (10.65) | 0.001 |
BMI, Body Mass Index; BFP, Body-fat Percentage; Pre, 1 day before the first cycle of docetaxel administration; Post, 21 days after the last cycle of docetaxel administration.
a
The differences in the probiotics group 1 day before the first cycle of docetaxel administration and 21 days after the last cycle of docetaxel administration based on t-test.
b
The differences in the placebo group 1 day before the first cycle of docetaxel administration and 21 days after the last cycle of docetaxel administration based on t-test.